Ali Dianaty - 15 Oct 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Reporting relationship: EVP Ch. Prod. & Tech Officer
Issuer ticker: MMED
Reported as of: 15 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Oct 2026, 18:49:39 UTC
Prior SEC filing: 04 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan F. Kelly, attorney-in-fact

Filing notes and source

Key filing fact

Ali Dianaty filed Form 4 for MiniMed Group, Inc. (MMED) on 19 Oct 2026.

Key facts

This page summarizes Ali Dianaty's Form 4 filing for MiniMed Group, Inc. (MMED).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Oct 2026, 18:49.

Change

Previous filing in this sequence was filed on 04 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111492 Primary reporting owner

Dianaty Ali

Relationship: EVP Ch. Prod. & Tech Officer
Address: C/O MINIMED GROUP, INC., 18000 DEVONSHIRE STREET, NORTHRIDGE
Signature: /s/ Bryan F. Kelly, attorney-in-fact
Signature date: 19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMED transaction

Common Stock

Award

Transaction value
Shares: +11,108
Change %: +3.5%
Price
Shares after: 326,266
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On October 15, 2026, MiniMed Group, Inc. ("MiniMed") issued shares of its common stock to the Reporting Person in connection with the completion of an exchange offer of up to an aggregate of 252,813,348 newly issued shares of common stock of MiniMed in exchange for outstanding ordinary shares of Medtronic plc ("Medtronic"). The final exchange ratio was 4.5939 shares of MiniMed common stock for each ordinary share of Medtronic accepted in the exchange offer. As a result, the Reporting Person received 11,108 shares of MiniMed common stock in exchange for 2,418 ordinary shares of Medtronic accepted in the exchange offer.

Footnote F2

Includes shares of common stock to be issued in connection with the vesting of one or more restricted stock units.